No. Melatonin is an indoleamine, not a peptide. Its chemical name is N-acetyl-5-methoxytryptamine. Although its biosynthesis begins with the amino acid tryptophan, its final structure is not a chain of amino-acid residues joined by peptide bonds. This distinction depends on molecular connectivity, not biological role or catalog placement.
What kind of molecule is melatonin?
Melatonin contains an indole ring system—two fused rings, one containing nitrogen—along with methoxy and N-acetyl groups. The chemical structure report by Lerner and colleagues [2] concerns the compound's molecular identity, rather than a human, animal, in-vitro, or in-silico outcome study. That structure identifies an indoleamine without a peptide backbone; it does not characterize any Alpha Carbon Labs batch.
Several descriptions can apply to melatonin because they address different aspects of the molecule:
- Indoleamine identifies its chemical family.
- Small molecule describes its relatively compact molecular structure.
- Hormone describes its biological signaling role, not its structural class.
- Peptide describes a structure with amino-acid residues connected by peptide bonds. Melatonin does not have that structure.
The name in the Melatonin listing denotes this chemical identity. Establishing whether a particular laboratory batch matches the stated identity requires batch-specific analytical evidence.
Why does a tryptophan origin not make melatonin a peptide?
Being derived from an amino acid differs from being assembled as an amino-acid chain. Melatonin biosynthesis modifies a tryptophan-derived structure. Peptide formation connects amino-acid residues into a sequence.
A simplified biosynthetic pathway is tryptophan → serotonin → N-acetylserotonin → melatonin, with intermediate steps omitted. Reiter's review [3] discusses this pathway in the context of pineal cell biology and synthesis. It is a review of biochemical literature, not a single experimental population or a test of commercial material. The pathway illustrates molecular transformations rather than assembly of tryptophan residues into a peptide chain.
An amide group is not automatically a peptide bond
Melatonin contains an amide group, but that group does not connect two amino-acid residues into a peptide backbone. This is a structural distinction based on the chemical identity described in the structure report [2], not a biological assay result. An amide group alone is insufficient to classify a compound as a peptide.
Likewise, “contains nitrogen” and “is derived from an amino acid” are not adequate classification rules. Classification requires examining how the atoms and functional groups are connected throughout the molecule.
Can a hormone be something other than a peptide?
Yes. Hormone is a functional category, not a single molecular class. Melatonin is an indoleamine hormone, whereas oxytocin is a peptide hormone containing nine amino-acid residues. Their signaling roles do not make their structures equivalent.
The reverse distinction also matters: not every peptide is a hormone. Glutathione is a tripeptide composed of glutamate, cysteine, and glycine, rather than a classical endocrine hormone. Laboratory records should distinguish structural classification from biological function.
Which catalog compounds are peptides?
The following comparison addresses molecular identity only. It does not compare biological outcomes, experimental performance, or the suitability of particular products for a protocol.
| Compound | Molecular class | Peptide? | Structural distinction |
|---|---|---|---|
| Melatonin | Indoleamine; amino-acid-derived small molecule | No | Contains an indole ring system, not an amino-acid chain |
| Oxytocin | Peptide hormone | Yes | Contains nine linked amino-acid residues |
| MK-677 (Ibutamoren) | Non-peptide small molecule | No | Does not have a peptide amino-acid sequence |
| 5-Amino-1MQ | Non-peptide small molecule | No | Is not a chain of amino-acid residues |
| NAD+ | Dinucleotide coenzyme | No | Contains two linked nucleotide units, not a peptide backbone |
| Glutathione | Tripeptide | Yes | Contains glutamate, cysteine, and glycine residues |
A functional label does not determine whether a compound is a peptide. For example, identifying NAD+ as a coenzyme does not make it an amino-acid chain. Molecular connectivity is the deciding criterion in this comparison.
Why can a peptide catalog include melatonin?
A laboratory supplier's catalog can contain several molecular classes organized under shared research topics. Peptides, indoleamines, other small molecules, and coenzymes can appear together without sharing the same structural features.
A navigation category is not a chemical specification. Describing melatonin as a research compound is compatible with its identity; describing melatonin itself as a peptide is not.
Shared catalog placement does not establish interchangeability, compatibility in an experiment, or comparable results. Published work on a named compound does not establish the identity, purity, or behavior of an Alpha Carbon Labs batch without direct supporting evidence.
How should researchers check molecular identity?
Start with the exact chemical name and structure rather than the category name, packaging, or research theme. For melatonin, the relevant identity is N-acetyl-5-methoxytryptamine. For a peptide, look for an amino-acid sequence or a structure showing the linked residues.
- Match the compound name to its structure. Similar names and neighboring listings do not establish related chemistry.
- Distinguish structural descriptions. Indoleamine, dinucleotide, and peptide describe different molecular features.
- Separate identity from purity. A purity percentage alone does not establish which compound was measured or whether it is a peptide.
- Check batch-specific documentation. The stated compound identity and batch reference should match the material being evaluated.
- Review analytical methods and limitations. Interpret each result according to what the method measures. A single reported result is not a complete characterization.
Alpha Carbon Labs' COA documents and quality-control information are resources for reviewing available documentation. These links do not establish that every batch has undergone the same testing or that any particular analytical specification has been met.
For the manufacturing distinction, see the peptide synthesis page. Peptide synthesis concerns assembling amino-acid sequences; it should not be assumed to describe the production of non-peptide materials in the same catalog.
Frequently asked questions
Is melatonin an amino acid?
No. Amino-acid-derived describes its biosynthetic origin, not its final molecular class. Melatonin is N-acetyl-5-methoxytryptamine, an indoleamine rather than an amino acid.
Is melatonin a protein or a steroid?
Neither. It lacks both the amino-acid-chain structure of proteins and the characteristic four-ring core of steroids. The word hormone does not place a molecule in either category.
Does synthetic melatonin become a peptide?
No. Synthetic describes production, whereas peptide describes structure. A substance with melatonin's chemical structure remains an indoleamine regardless of its production route. That classification does not establish equivalence between batches, impurity profiles, or experimental performance.
Does melatonin have an amino-acid sequence?
No. Melatonin is not a chain of amino-acid residues. Its identity is described by a chemical name, molecular formula, and structure rather than a peptide sequence.
Are all products sold by peptide suppliers peptides?
No. A supplier's range can include several molecular classes. Check the individual chemical identity rather than treating a storefront category as a structural definition.
Does non-peptide mean lower laboratory hazard?
No. Non-peptide is a structural label, not a hazard rating. Laboratory handling requires substance-specific hazard information and an assessment of the experimental conditions. Review the applicable safety data sheet and institutional procedures; molecular classification alone is insufficient.
Key takeaway
Melatonin is an indoleamine, not a peptide. Its tryptophan origin, amide group, and catalog placement do not give it a peptide backbone. For laboratory documentation, keep chemical identity, biosynthetic origin, biological role, and batch-specific analytical evidence separate.
References
- [1] Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocytes. Journal of the American Chemical Society. 1958;80:2587.
- [2] Lerner AB, Case JD, Heinzelman RV. Structure of melatonin. Journal of the American Chemical Society. 1959;81:6084–6085.
- [3] Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Reviews. 1991;12(2):151–180.
- [4] du Vigneaud V, Ressler C, Swan JM, Roberts CW, Katsoyannis PG, Gordon S. The synthesis of an octapeptide amide with the hormonal activity of oxytocin. Journal of the American Chemical Society. 1953;75:4879–4880.
- [5] Patchett AA, et al. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proceedings of the National Academy of Sciences of the United States of America. 1995;92(15):7001–7005.
- [6] Neelakantan H, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochemical Pharmacology. 2018;147:141–152.
- [7] Belenky P, Bogan KL, Brenner C. NAD+ metabolism in health and disease. Trends in Biochemical Sciences. 2007;32(1):12–19.
- [8] Meister A, Anderson ME. Glutathione. Annual Review of Biochemistry. 1983;52:711–760.
Limitations: This article addresses chemical classification, not product validation. Alpha Carbon Labs materials are intended solely for nonclinical laboratory research. Published findings do not establish safety, effectiveness, approval, or suitability of the material sold for human or veterinary use.